• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON GMBH PREMICATH; LONG-TERM INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON GMBH PREMICATH; LONG-TERM INTRAVASCULAR CATHETER Back to Search Results
Model Number 1261.203
Device Problems Break (1069); Material Fragmentation (1261)
Patient Problems Device Embedded In Tissue or Plaque (3165); No Information (3190)
Event Date 02/04/2020
Event Type  Injury  
Manufacturer Narrative
The results of this investigation are pending and will be communicated to fda within 30 days of its conclusion via follow up mdr.
 
Event Description
Patient with 5 days of life born at 31 weeks to whom premicath is inserted.After observing difficulty in the insertion and progression of the catheter, the nurse notes that 1.5 cm of the catheter tip is missing and remains lodged in the patient.An x-ray is taken and it is checked that it is placed in the vein.
 
Manufacturer Narrative
This complaint is not confirmed.We just received the distal 2,3 cm (with tip marking) catheter tube fragment as a sample - obviously the part which surgically had to be removed.Fibrines were adhering to the tube.The proximal part of the catheter had been rejected by the customer.Microscopical examination showed typical signs for a cut and torn catheter tube.A superficial cut on the catheter tube next to the rupture was visible.Therefore we assume that the catheter tube got damaged by the needle bevel during insertion process and could snap at that area when trying to place the catheter in it's correct position.We have a special hint the product's ifu: ""important caution: at no time should the catheter be withdrawn back through a splitting needle.If it becomes impossible to advance the catheter into a satisfactory position, then the needle and catheter must be withdrawn simultaneously.The result of withdrawing a catheter back through the needle can be catheter embolism."" having checked the batch history records, no deviations were found.Each catheter is flow and leak tested during production.The tensile force of the catheter components is randomly checked.Visual tests and incoming goods inspections are carried out.This is the second complaint for batch 040919gm and the third regarding a snapped catheter during placement on code 1261.203.No further corrective action initiated by quality management as there is no hint for a manufacturing fault.".
 
Event Description
Patient with 5 days of life born at 31 weeks to whom premicath is inserted.After observing difficulty in the insertion and progression of the catheter, the nurse notes that 1.5 cm of the catheter tip is missing and remains lodged in the patient.An x-ray is taken and it is checked that it is placed in the vein.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PREMICATH
Type of Device
LONG-TERM INTRAVASCULAR CATHETER
Manufacturer (Section D)
VYGON GMBH
prager ring 100
aachen, 52070
GM  52070
MDR Report Key9705708
MDR Text Key179423777
Report Number2245270-2020-00007
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
PMA/PMN Number
K041468
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 04/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number1261.203
Device Lot Number040919GM
Was Device Available for Evaluation? Yes
Date Manufacturer Received02/11/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-